Study summary

The purpose of this study is to evaluate the efficacy of ASP8232 in reducing Urinary Albumin to Creatinine Ratio (UACR) in subjects with Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) at 12 weeks compared to placebo.

Additional Study Details

Phase
2
Product
N/A
Product
ASP8232
Placebo
Type
Interventional
Masking
Triple (Participant, Investigator, Outcomes Assessor)
Enrollment number
125
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients with Type 2 Diabetes and Chronic Kidney Disease? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Site ES34004
    Barcelona, Barcelona, Spain, 08035
    Completed
    Site PL48006
    Rzeszow, Poland, 35-055
    Completed
    Site DK45006
    Viborg, Denmark, 8800
    Completed
    Site GB44005
    London, United Kingdom, SE1 9RT
    Completed
    Site ES34005
    Barcelona, Spain, 08025
    Completed
    Site IT39005
    Pavia, Italy, 27100
    Completed
    Site ES34001
    Barcelona, Barcelona, Spain, 08003
    Completed
    Site CZ42002
    Brno, Czech Republic
    Completed
    Site ES34006
    Lugo, Spain, 27880
    Completed
    Site DE49002
    Düsseldorf, Germany, 40210
    Completed
    Site PL48004
    Lodz, Poland, 94-225
    Completed
    Site CZ42003
    Ceské Budejovice, Czech Republic, 370 01
    Completed
    Site PL48003
    Plock, Poland, 09-402
    Completed
    Site HU36017
    Szekesfehervar, Hungary, 8000
    Completed
    Site DK45004
    Gentofte, Denmark, 2820
    Completed
    Site PL48008
    Lodz, Poland, 94-048
    Completed
    Site IT39012
    Rome, Italy, 00189
    Completed
    Site IT39004
    Turin, Italy, 10141
    Withdrawn
    Site BE32004
    Roeselare, Belgium, 8800
    Completed
    Site CZ42005
    Praha 10, Czech Republic, 108 00
    Completed
    Site HU36003
    Hatvan, Hungary, H-3000
    Completed
    Site HU36010
    Budapest, Hungary, H-1096
    Completed
    Site ES34002
    Barcelona, Barcelona, Spain, 08907
    Completed
    Site HU36018
    Veszprem, Hungary, H- 8200
    Completed
    Site HU36012
    Kaposvar, Hungary, 7400
    Completed
    Site GB44004
    Burton-on-Trent, United Kingdom, DE13 0RB
    Completed
    Site CZ42001
    Prague 4, Czech Republic, 140 21
    Completed
    Site GB44001
    Chester, United Kingdom, CH2 1UL
    Withdrawn
    Site NL31002
    Eindhoven, Netherlands, 5631 BM
    Completed
    Site DK45001
    Herlev, Denmark, 2730
    Completed
    Site IT39007
    Bergamo, Italy, 24127
    Withdrawn
    Site DK45003
    Frederiksberg, Denmark, 2000
    Completed
    Site DE49008
    Elsterwerda, Germany, 04910
    Completed
    Site HU36016
    Budapest, Hungary, 1036
    Completed
    Site ES34003
    PALMA DE MALLORCA, Spain, 7120
    Completed
    Site GB44003
    South Yorkshire, United Kingdom, DN2 5LT
    Completed
    Site PL48005
    Sopot, Poland
    Withdrawn
    Site BE32002
    Brussels, Belgium, 1070
    Withdrawn
    Site DE49007
    Bosenheim, Germany, 55545
    Withdrawn
    Site PL48028
    Kraków, Poland, 30-069
    Completed
    Site PL48027
    Oświęcim, Poland, 32-600
    Completed
    Site HU36005
    Szikszó, Hungary
    Completed
    Site DE49003
    Heidelberg, Germany, 69115
    Completed
    Site DE49004
    Berlin, Germany, 13125
    Completed
    Site DK45002
    Hillerød, Denmark, 3400
    Completed
    Site DK45016
    Copenhagen, Denmark, 2400
    Completed
    Site NL31001
    Dordrecht, Netherlands, 3318 AT
    Completed
    Site PL48022
    Radom, Poland, 26-600
    Completed
    Site IT39002
    Piacenza, Italy, 29100
    Completed
    Site PL48001
    Poznan, Poland, 61655
    Completed
    Site DK45007
    Holsterbro, Denmark, 7500
    Completed
    Site HU36002
    Balatonfüred, Hungary, 8230
    Completed
    Site CZ42004
    Praha 9, Czech Republic, 190 00
    Completed
    Site ES34012
    Madrid, Spain, 28041
    Withdrawn
    Site DE49006
    Berlin, Germany, 13353
    Completed
    Site ES34010
    Majadahonda, Spain, 28222
    Completed
    Site ES34007
    Ciudad Real, Spain, 13005
    Completed
    Site PL48026
    Lodz, Poland, 90-302
    Completed
    Site NL31004
    Rotterdam, Zuid-Holland, Netherlands, 3045 PM
    Completed
    Site ES34008
    Madrid, Spain, 28007
    Completed
    Site PL48025
    Warszawa, Poland, 00-660
    Completed
    Site NL31003
    Hoogeveen, Netherlands, 7909 AA
    Withdrawn
    Site BE32001
    Brussels, Belgium, 1090
    Completed
    Site HU36007
    Szigetvar, Hungary, 7900
    Completed
    Site PL48002
    Torun, Poland, 87-100

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?